Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marin

Showing results (191-200 of 197) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 197 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myelomaAlice Y Zhou, Nancy D Marin, Sadia Afrin, et al.
Science Immunology|June 28, 2024
Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulationJennifer A Foltz, Jennifer Tran, Pamela Wong, et al.
The Journal of Clinical Investigation|June 6, 2023
T-BET and EOMES sustain mature human NK cell identity and antitumor functionPamela Wong, Jennifer A Foltz, Lily Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2023
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck CancerMiriam T Jacobs, Pamela Wong, Alice Y Zhou, et al.
Nature Communications|July 13, 2026
Nrf2-mediated metabolic reprogramming drives regulatory T cell accumulation in hepatocellular carcinomaE Perpiñán, N Sompairac, D Marin Correa, et al.
Science Translational Medicine|February 23, 2022
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemiaMelissa M Berrien-Elliott, Jennifer A Foltz, David A Russler-Germain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2021
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30<sup>+</sup> MalignanciesLucila N Kerbauy, Nancy D Marin, Mecit Kaplan, et al.
Pageof 20

Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myelomaAlice Y Zhou, Nancy D Marin, Sadia Afrin, et al.
Science Immunology|June 28, 2024
Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulationJennifer A Foltz, Jennifer Tran, Pamela Wong, et al.
The Journal of Clinical Investigation|June 6, 2023
T-BET and EOMES sustain mature human NK cell identity and antitumor functionPamela Wong, Jennifer A Foltz, Lily Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2023
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck CancerMiriam T Jacobs, Pamela Wong, Alice Y Zhou, et al.
Nature Communications|July 13, 2026
Nrf2-mediated metabolic reprogramming drives regulatory T cell accumulation in hepatocellular carcinomaE Perpiñán, N Sompairac, D Marin Correa, et al.
Science Translational Medicine|February 23, 2022
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemiaMelissa M Berrien-Elliott, Jennifer A Foltz, David A Russler-Germain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2021
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30<sup>+</sup> MalignanciesLucila N Kerbauy, Nancy D Marin, Mecit Kaplan, et al.
Pageof 20